<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15895">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02899962</url>
  </required_header>
  <id_info>
    <org_study_id>LP0053-1004</org_study_id>
    <nct_id>NCT02899962</nct_id>
  </id_info>
  <brief_title>LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris</brief_title>
  <official_title>LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LEO Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LEO Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol
      foam vehicle used twice weekly as long-term maintenance therapy in subjects with psoriasis
      vulgaris.

      A 12-month, international, multi-centre, randomised, vehicle controlled, double-blind,
      2-arm, parallel group trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After an initial 4-week period of once-daily treatment with open-label active LEO 90100
      aerosol foam, subjects who qualify for randomisation will continue into a 52-week
      maintenance treatment period with twice-weekly application of randomised LEO 90100 aerosol
      foam / LEO 90100 aerosol foam vehicle.

      If the subject experiences a relapse of psoriasis, the active lesions will be treated for 4
      weeks with open-label active LEO 90100 aerosol foam.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first relapse</measure>
    <time_frame>From Randomisation (Week 4; Visit 2) until End of Treatment (Week 56; Visit 15)</time_frame>
    <description>Relapse defined as at least &quot;mild&quot; according to the PGA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of days in remission during the maintenance phase</measure>
    <time_frame>From Randomisation (Week 4; Visit 2) until End of Treatment (Week 56; Visit 15)</time_frame>
    <description>Remission defined as 'clear' or 'almost clear' according to the PGA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses during the maintenance phase</measure>
    <time_frame>From Randomisation (Week 4;Visit 2) until End of Treatment (Week 56; Visit 15)</time_frame>
    <description>Defined as number of 4-week periods with use of once-daily rescue IMP</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">832</enrollment>
  <condition>Psoriasis Vulgaris</condition>
  <arm_group>
    <arm_group_label>LEO 90100 aerosol foam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical application twice weekly for 52 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LEO 90100 aerosol foam vehicle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Topical application twice weekly for 52 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LEO 90100 aerosol foam</intervention_name>
    <description>LEO 90100 aerosol foam twice weekly</description>
    <arm_group_label>LEO 90100 aerosol foam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LEO 90100 aerosol foam vehicle</intervention_name>
    <description>LEO 90100 aerosol foam vehicle twice weekly</description>
    <arm_group_label>LEO 90100 aerosol foam vehicle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:

          -  A clinical diagnosis of psoriasis vulgaris for at least 6 months involving the trunk
             and/or limbs, amenable to treatment with maximum of 100 g of trial medication per
             week

          -  Psoriasis vulgaris on the trunk and/or limbs (excluding psoriasis on the genitals and
             skin folds) involving 2-30% of the body surface area (BSA)

          -  A target lesion/target location of at least 3 cm at its longest axis located on the
             body (i.e., not on the scalp, face or intertriginous areas), scoring at least 1
             ('mild') for each of redness, thickness and scaliness, and at least 4 in total by the
             Investigator's Assessment of Severity of the Target Lesion/Location

        For subjects participating in HPA-axis testing, furthermore:

          -  An extent of psoriasis vulgaris on trunk and/or limbs of disease severity (PGA) of at
             least 'moderate' affecting between 10 and 30% of the body surface area (BSA)
             excluding psoriatic lesions of genitals and skin folds at Visit 1.

        EXCLUSION CRITERIA:

          -  Systemic treatment with biological therapies, whether marketed or not, with a
             possible effect on psoriasis vulgaris within the following time periods prior to
             Visit 1:

               -  etanercept - within 4 weeks prior to Visit 1

               -  adalimumab, infliximab - within 8 weeks prior to Visit 1

               -  ustekinumab - within 16 weeks prior to Visit 1

               -  secukinumab - within 12 weeks prior to Visit 1

               -  other products - within 4 weeks/5 half-lives prior to Visit 1 (whichever is
                  longer)

          -  Systemic treatment with all other therapies with a possible effect on psoriasis
             vulgaris (e.g. corticosteroids, retinoids, methotrexate, ciclosporin and other
             immunosuppressants) within 4 weeks prior to Visit 1

          -  Systemic treatment with apremilast within 4 weeks prior to Visit 1

          -  Psoralen combined with Ultraviolet A (PUVA) therapy within 4 weeks prior to Visit 1

          -  Ultraviolet B (UVB) therapy within 2 weeks prior to Visit 1

          -  Severe and/or extensive scalp psoriasis which, in the opinion of the investigator,
             requires treatment with potent or super-potent corticosteroids which will be
             prohibited during the trial

        For subjects participating in HPA-axis testing, furthermore:

          -  Antidepressive medications within 4 weeks prior to Visit 1 or during the trial.
             Oestrogen therapy (including contraceptives), antidepressant medications and any
             other medication known to affect cortisol levels or HPA axis integrity within 4 weeks
             prior to baseline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Lebwohl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bente Tholstrup, MSc Pharmacy</last_name>
    <phone>+45 4494 5888</phone>
    <email>ebodk@leo-pharma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jane Christensen</last_name>
    <phone>+45 7226 2734</phone>
    <email>jxcdk@leo-pharma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Dermatology Clinical Research</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil Dhawan, Dr.</last_name>
      <email>nataliac@ctr4derm.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF Psoriasis Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tina Bhutani, Dr.</last_name>
      <email>psoriasisresearch@derm.ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Science Institute</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Yamauchi, Dr.</last_name>
      <email>dryamauchi@csird.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Colorado Medical Research Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Swinehart, Dr.</last_name>
      <email>cmrc@pcisys.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>International Dermatology Research</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Javier Alonso-Llamazares, Dr.</last_name>
      <email>info@intldermresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arlington Dermatology</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Bukhalo, Dr.</last_name>
      <email>bukhalom@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Derm Research</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40217</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leon Kircik, Dr.</last_name>
      <email>wedoderm@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DermAssociates</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ben Lockshin, Dr.</last_name>
      <email>jcoffy@dermassociates.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clarkston Skin Research</name>
      <address>
        <city>Clarkston</city>
        <state>Michigan</state>
        <zip>48346</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy McFlada, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Brianna E. Cole, CCRC</last_name>
      <email>Bodonnell@clarkstonderm.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Henry Ford Medical Center - New Center One</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Stein-Gold, Dr.</last_name>
      <email>dleaman1@hfhs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beyer Research</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roger Beyer, Dr.</last_name>
      <email>info@beyerresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Psoriasis Treatment Center of Central NJ</name>
      <address>
        <city>East Windsor</city>
        <state>New Jersey</state>
        <zip>08520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jerry Bagel, Dr</last_name>
      <email>dreamacres1@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Lebwohl, MD</last_name>
      <phone>212-241-9728</phone>
      <email>Mark.lebwohl@mountsinai.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sadick Research Group</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Neil Sadick, Dr.</last_name>
      <email>SRG@sadickdermatology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Skin Search of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14623</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Tu, Dr.</last_name>
      <email>skinsearch@dermrochester.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steve Feldman, Dr.</last_name>
      <email>dermadvertising@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Department of Dermatology</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Ferris, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Charity L. Ruhl</last_name>
      <email>ruhlcl@upmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rivergate Dermatology Clinical Research Center</name>
      <address>
        <city>Goodlettsville</city>
        <state>Tennessee</state>
        <zip>37072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Loven, Dr.</last_name>
      <email>amccarroll@Rivderm.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Skin Wellness Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37922</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Grande, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Jennifer Wilson</last_name>
      <email>Jwilson.swc@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tennessee Clinical Research Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Gold, Dr.</last_name>
      <email>mgold@tnclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of Texas</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terri Nutt, Dr.</last_name>
      <email>KScroggins@cttexas.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Studies</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Tyring, Dr.</last_name>
      <email>info@ccstexas.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Premier Clinical Research</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William P. Werschler, Dr.</last_name>
      <email>pkwerschle@aol.com</email>
    </contact>
    <contact_backup>
      <email>reg@premierclinicalresearch.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dr. Chih-ho Hong Medical</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <zip>V3R 6A7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chih-ho Hong, Dr.</last_name>
      <email>theresa@dermis.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pacific Dermaesthetics</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6E 4M3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Rivers, Dr.</last_name>
      <email>studies@pacificderm.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wiseman Dermatology Research</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3M 3Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marni Wiseman, Dr.</last_name>
      <email>lovie@skinwise.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maritime Medical Research Centre</name>
      <address>
        <city>Bathurst</city>
        <state>New Brunswick</state>
        <zip>E2A 4Z9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>France Lepage, Dr.</last_name>
      <email>maritimes@research-center.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brunwick Dermatology Center</name>
      <address>
        <city>Fredericton</city>
        <state>New Brunswick</state>
        <zip>E3B 1G9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Turchin, Dr.</last_name>
      <email>iturchin@ucalgary.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCA Medical Research</name>
      <address>
        <city>Ajax</city>
        <state>Ontario</state>
        <zip>L1S 7K8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Adam, Dr.</last_name>
      <email>info@ccamedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dermatrials Research Incorporated</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1V6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Vender, Dr.</last_name>
      <email>laura@dermatrials.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Guenther Dermatology Research Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 3B4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyn Guenther, Dr.</last_name>
      <email>dgue@guenthermpc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lynderm Research</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>L3P 1X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Lynde, Dr.</last_name>
      <email>derma@lynderma.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SKiN Center for Dermatology</name>
      <address>
        <city>Peterborough</city>
        <state>Ontario</state>
        <zip>K9J 5K2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melinda Gooderham, Dr.</last_name>
      <email>fisher4@sympatico.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>K. Papp Clinical Research</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2J 1C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Papp, Dr.</last_name>
      <email>ronda@kpappclinical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Dre Isabelle Delorme Inc</name>
      <address>
        <city>Quebec</city>
        <zip>J2B 5L4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Delorme, Dr.</last_name>
      <email>lplante@dredelorme.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>C.H.U. de Saint-Etienne Service de Dermatologie</name>
      <address>
        <city>Saint Etienne</city>
        <state>Saint-Etienne</state>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric Cambazard, Dr</last_name>
      <email>frederic.cambazard@chu-st-etienne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Brest - Hôpital Morvan</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent Misery, Dr</last_name>
      <email>clemence.kergourlay@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe Bedane, Dr</last_name>
      <email>arc-dermato@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>C.H.U. de nice, Hôpital de l'Archet II, Service de Dermatologie-Vénérologie</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe Lacour, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Maryse Clappier</last_name>
      <email>maryse.clappier@unice.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinique de Courlancy</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ziad Reguai, Dr</last_name>
      <email>ziad.reguiai@ra.sirtem.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Perrussel, Dr</last_name>
      <email>Elise.THEBAULT@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francois Skowron, Dr</last_name>
      <email>fskowron@ch-valence.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Dermatologie</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan Beissert, Prof.Dr.</last_name>
      <email>Katharina.Bluemlein@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sticherling, Prof.Dr.med.</last_name>
      <email>pso.studien@uk-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen (AöR), Klinik für Dermatologie</name>
      <address>
        <city>Essen</city>
        <zip>54122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Körber, Dr.med.</last_name>
      <email>Katrin.Heller@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SRH Wald-Klinikum Gera</name>
      <address>
        <city>Gera</city>
        <zip>07548</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Sell, Dr.</last_name>
      <email>studienzentrum@wkg.srh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCIderm GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20354</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Weisenseel, Dr.med.</last_name>
      <email>peter.weisenseel@tfscro.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios-Kliniken Krefeld Klinik</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chalid Assaf, Prof.Dr.med.</last_name>
      <email>laura.gaspardo@helios-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UKSH - Campus Lübeck</name>
      <address>
        <city>Lubeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diamant Thaci, Prof.Dr.</last_name>
      <email>yves.trense@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michael Sebastian</name>
      <address>
        <city>Mahlow</city>
        <zip>15831</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sebastian, Dr.med.</last_name>
      <email>kontakt@hautarztpraxis-mahlow.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LMU Poliklinik Derma &amp; Allergo</name>
      <address>
        <city>Munchen</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonja Molin, Dr.</last_name>
      <email>DASZ@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemein. Weber &amp; Crainic</name>
      <address>
        <city>Schweinfurt</city>
        <zip>97421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ridwan Weber, Dr.med.</last_name>
      <email>info@wedermic.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wansford and Kings Cliffe Prac</name>
      <address>
        <city>Wansford</city>
        <state>Cambridgeshire</state>
        <zip>PE8 6PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amrit Takhar, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ashgate Medical Practice</name>
      <address>
        <city>Chesterfield</city>
        <state>Derbyshire</state>
        <zip>S40 4AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Blagden, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Burbage Surgery</name>
      <address>
        <city>Burbage</city>
        <state>Leicstershire</state>
        <zip>LE10 2SE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wayne Turner, Dr</last_name>
      <email>mick.walker@burbagesurgery.co.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albany House Medical Centre</name>
      <address>
        <city>Wellingborough</city>
        <state>Northamptonshire</state>
        <zip>NN8 4RW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Nwafor, Dr</last_name>
      <email>ahmcresearch@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sherbourne Medical Centre</name>
      <address>
        <city>Leamington Spa</city>
        <state>Warwickshire</state>
        <zip>CV32 4RA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Ainsworth, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chapel Allerton Hospital</name>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS7 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phillip Laws, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dermatopharmacology Department</name>
      <address>
        <city>Salford</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Warren, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 7, 2017</lastchanged_date>
  <firstreceived_date>September 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
